Identification of human uroplakin II promoter and its use in the construction of CG8840, a urothelium-specific adenovirus variant that eliminates established bladder tumors in combination with docetaxel

Cancer Research

Volumn 62, Issue 13, 2002, Pages 3743-3750

  Zhang, Jane ^a   Ramesh, Nagarajan ^a   Chen, Yu ^a   Li, Yuanhao ^a   Dilley, Jeanette ^a   Working, Peter ^a   Yu, De Chao ^a  

^a CELL GENESYS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DOCETAXEL; DOXORUBICIN; UROPLAKIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CARCINOMA; BRAIN CANCER; CANCER INHIBITION; CELL DIFFERENTIATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG FIBROBLAST; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SMOOTH MUSCLE FIBER; TRANSITIONAL CELL CARCINOMA; UROTHELIUM; VIRUS REPLICATION;

ADENOVIRUS E1B PROTEINS; ADENOVIRUSES, HUMAN; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; CYTOPATHOGENIC EFFECT, VIRAL; DRUG SYNERGISM; GENE DELETION; GENES, REGULATOR; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; PACLITAXEL; PROMOTER REGIONS (GENETICS); TAXOIDS; URINARY BLADDER NEOPLASMS; VIRUS REPLICATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0036645430     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Lumenal plasma membrane of the urinary bladder. I. Three-dimensional reconstruction from freeze-etch images
2. Lumenal plasma membrane of the urinary bladder. II. Isolation and structure of membrane components
3. Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins
4. Large scale purification and immunolocalization of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation
5. Molecular cloning of a 47-kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein
6. Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas
7. Sun a 27-kD protein associated with the asymmetric unit membrane of mammalian urothelium
8. Biology and management of bladder cancer
9. Prostate attenuated replication competent adenovirus (ARCA) CN706: A selective cytotoxic for prostate-specific antigen-positive prostate cancer cells
10. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy
11. Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel
12. CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity
13. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin
14. A Phase I trial of CV706, a replication-competent, PSA-selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy
15. Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: Alternative pathways of bladder epithelial differentiation and tumor formation
16. The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts
17. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
18. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability
19. Gene regulation by steroid hormones
20. A consensus DNA-binding site for the androgen receptor
21. A tissue-specific promoter that can drive a foreign gene to express in the suprabasal urothelial cells of transgenic mice
22. Uroplakin gene expression by normal and neoplastic human urothelium
23. Detection of circulating cancer cells by reverse transcription- polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer
24. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor α
25. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins
26. Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector
27. Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved. Deletion of the viral E1b-19-kD gene increases the viral oncolytic effect
28. Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity
29. Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines
30. Absence of an essential regulatory influence of the adenovirus E1B 19-kilodalton protein on viral growth and early gene expression in human diploid W138, HeLa, and A549 cells
31. Induced apoptosis supports spread of adenovirus vectors in tumors